Navigation Links
Solazyme Selected for National Institute of Standards and Technology Award
Date:9/27/2007

$2 Million Grant to Support Development of Renewable Replacement for Light

Sweet Crude Oil

SOUTH SAN FRANCISCO, Calif., Sept. 27 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has received a $2 million Advanced Technology Program Award from the National Institute of Standards and Technology to develop a biopetroleum derived from marine microorganisms.

Under the program, Solazyme will accelerate development of a renewable, domestically produced light sweet crude oil, or biopetroleum, which is fully compatible with the vast existing petroleum industry infrastructure that refines, distributes, and markets petroleum products for transportation, heating, power generation and petrochemical applications. Development of the biopetroleum technology requires efficient industrial scale bioproduction of pure, long-chain hydrocarbons. The ATP award will advance the achievement of major technical milestones toward commercialization of biopetroleum.

"We are pleased to receive external peer reviewed validation of our progress in developing a commercially viable biopetroleum," said Arthur Grossman, chief of genetics for Solazyme, Senior Scientist at the Carnegie Institution, Courtesy Professor at Stanford University and Darbaker prize recipient. "We look forward to advancing this project and adding additional technical expertise to our team as we continue to further the science and the future applications of algal-derived bioenergy."

Solazyme is currently developing biofuels and health/wellness products with microalgae and producing next generation biofuels at the semi-commercial scale. Biopetroleum complements Solazyme's biofuel portfolio, which also includes biodiesel, renewable diesel and renewable (bio)jet fuel and leverages Solazyme's unique expertise in the field of microalgae bioengineering.

"The Advanced Technology Program has historically funded the development of game-changing technologies and we are delighted to be in such esteemed company," added Harrison Dillon, chief executive officer of Solazyme. "The scientific strategy underlying our approach to create biopetroleum will leverage Solazyme's core strengths in the genetic manipulation of microalgae and potentially play a significant role in securing US energy independence."

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website: http://www.solazyme.com.

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

jkolek@peppercom.com esnook@peppercom.com


'/>"/>
SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. San Diego firm selected for Madison Wi-Fi project
2. Milwaukee-based eFilm software selected by InSight Health, announces Workstation upgrade
3. Berbee Selected by Microsoft as Featured Speaker for New Product Launch
4. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
5. Schneider National exec joins TrafficCast board
6. Olympics of biotechnology has international flavor
7. Wisconsin professors elected to National Academy of Sciences
8. CIO Leadership Series: Judy Lemke, Schneider National
9. National angel investment grew 11 percent in `06
10. National broadband policy: Lets get it right this time
11. National Academies induct five UW researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Diversity focused business accelerator, The ... Growth pitch competition to uncover the top technology-driven, women-led startups in Boston, MA, New ... of each city’s entrepreneurial events going on that week – in Boston, it will ...
(Date:9/20/2017)... Palo Alto, CA (PRWEB) , ... September 20, ... ... and public interest organization focused on molecular manufacturing and other transformative technologies, announced ... categories, one for Experiment and the other for Theory in nanotechnology/molecular manufacturing. , ...
(Date:9/19/2017)... ... , ... VetStem Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, is featured ... Cell Therapy: A Rising Tide". Dr. Harman and Dr. Riordan met in 2003 and ... in the potential of stem cell therapy and a fast friendship was formed. , Dr. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... today announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ ... image analysis to isolate single cells and provide visual documentation of monoclonality for ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 No two people are ... the New York University Tandon School of Engineering ... found that partial similarities between prints are common ... mobile phones and other electronic devices can be ... vulnerability lies in the fact that fingerprint-based authentication ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
Breaking Biology News(10 mins):